Galectin-8 is currently limited in pancreatic cancer, but in other solid cancers, it exhibits potent pro-inflammatory effects, suppresses immune cell function in tumor cells, and promotes tumorigenesis [139]. The gene discussed is LGALS8; the disease is neoplasm.